DDM-008 - Real-world utilisation, efficacy, and safety of injectable GLP-1 receptor agonists: A drug use evaluation in Singapore's largest healthcare cluster

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: DDM-008
• By: LEOW, Jo Lene (Singapore Health Services, Singapore)
• Co-author(s): Dr Jo Lene Leow (Singapore Health Services, Singapore, Singapore)
  Dr Wei Xiang Tong (Changi General Hospital, Singapore, Singapore)
  Ms Jamie Stephanie (KK Women's and Children's Hospital, Singapore, Singapore)
  Mr Siew Chong Teo (National Heart Centre Singapore, Singapore, Singapore)
  Dr Xiu Yun Ang (Singapore General Hospital, Singapore, Singapore)
  Ms Joyce Lim (Sengkang General Hospital, Singapore, Singapore)
  A/Prof Lita Chew (Singapore Health Services, Singapore, Singapore)
  Prof Lai Yun Ho (Singapore Health Services, Singapore, Singapore)
  
• Abstract:

  Introduction
  Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as essential therapies in the management of type 2 diabetes mellitus (T2DM) and obesity. This study aimed to conduct a comprehensive drug use evaluation (DUE) of injectable GLP-1RAs within Singapore's largest healthcare cluster, focusing on the appropriateness of..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login